A Beneficial Effect of Glatiramer Acetate (GA, Copaxone®) in Experimental Autoimmune Neuritis

被引：0
|
作者：
Chapman, Joab
Aronovich, Ramona
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [21] CD8+T cells are required for the therapeutic effects of glatiramer acetate (Copaxone) on autoimmune demyelination
    Mendoza, Jason
    York, Nathan
    Benagh, Andrew
    Firan, Mihail
    Karandikar, Nitin
    CLINICAL IMMUNOLOGY, 2008, 127 : S33 - S34
  • [22] Axoglatiran® FS: Generic of Copaxone® Preparation Based on Glatiramer Acetate
    Yu. V. Skornyakov
    A. A. Deryabin
    O. V. Skornyakova
    Pharmaceutical Chemistry Journal, 2017, 51 : 301 - 306
  • [23] Comparison of Copaxone® and Synthon's therapeutically equivalent glatiramer acetate
    Arends, R. J.
    Wang, D.
    Buurman, M.
    Luten, J.
    Koper, N. P.
    Wolf, C.
    Scheren, M.
    PHARMAZIE, 2019, 74 (08): : 449 - 461
  • [24] The role of T regulatory cells in the therapeutic effect of glatiramer acetate in experimental autoimmune encephalomyelitis
    Aharoni, R.
    Feferman, T.
    Bar Lev, D. D.
    Shakhar, G.
    Sela, M.
    Arnon, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 326 - 326
  • [25] Does glatiramer acetate induce neurogenesis in experimental autoimmune encephalomyelitis?
    Ruth Arnon
    Journal of Neurology, 2007, 254 : I41 - I46
  • [26] Does glatiramer acetate induce neurogenesis in experimental autoimmune encephalomyelitis?
    Arnon, Ruth
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 1) : 41 - 46
  • [27] Treatment with glatiramer acetate (Copaxone®) prevents neurodegeneration in patients with multiple sclerosis
    Jaworski, J.
    Leinhard, O. Dahlqvist
    Tisell, A.
    Lundberg, P.
    Landtblom, A. M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S140 - S141
  • [28] Characterization and Comparison of the Gene Expression Profiles of Copaxone® and Mylan Glatiramer Acetate
    Smith, Jeffrey
    Hsu, Chun-Nan
    Lipsky, Peter
    NEUROLOGY, 2018, 90
  • [29] Glatiramer acetate (copaxone) influences at different phases of pathogenesis of multiple sclerosis
    Schmidt, TE
    Zhuchenko, TD
    Yakhno, NN
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, : 79 - 82
  • [30] Determinants of treatment persistence with glatiramer acetate in the French national Copaxone registry
    Lebrun-Frenay, C.
    Moulignier, A.
    Pierrot-Deseilligny, C.
    Moreau, T.
    Salin, B.
    Monchecourt, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 331 - 332
12345